BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28401934)

  • 1. Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition.
    Hearps AC; Tyssen D; Srbinovski D; Bayigga L; Diaz DJD; Aldunate M; Cone RA; Gugasyan R; Anderson DJ; Tachedjian G
    Mucosal Immunol; 2017 Nov; 10(6):1480-1490. PubMed ID: 28401934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
    Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
    Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.
    Tyssen D; Wang YY; Hayward JA; Agius PA; DeLong K; Aldunate M; Ravel J; Moench TR; Cone RA; Tachedjian G
    mSphere; 2018 Jul; 3(4):. PubMed ID: 29976641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and antimicrobial properties differ between vaginal Lactobacillus isolates from South African women with non-optimal versus optimal microbiota.
    Manhanzva MT; Abrahams AG; Gamieldien H; Froissart R; Jaspan H; Jaumdally SZ; Barnabas SL; Dabee S; Bekker LG; Gray G; Passmore JS; Masson L
    Sci Rep; 2020 Apr; 10(1):6196. PubMed ID: 32277092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic acid enhances vaginal epithelial barrier integrity and ameliorates inflammatory effects of dysbiotic short chain fatty acids and HIV-1.
    Schwecht I; Nazli A; Gill B; Kaushic C
    Sci Rep; 2023 Nov; 13(1):20065. PubMed ID: 37973920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression.
    Delgado-Diaz DJ; Jesaveluk B; Hayward JA; Tyssen D; Alisoltani A; Potgieter M; Bell L; Ross E; Iranzadeh A; Allali I; Dabee S; Barnabas S; Gamieldien H; Blackburn JM; Mulder N; Smith SB; Edwards VL; Burgener AD; Bekker LG; Ravel J; Passmore JS; Masson L; Hearps AC; Tachedjian G
    Microbiome; 2022 Aug; 10(1):141. PubMed ID: 36045402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium
    Tyssen D; Hearps AC; Guntur K; Masson L; Cook S; Moulton SE; Ravel J; Bradshaw CS; Ayehunie S; Tachedjian G
    Front Reprod Health; 2022; 4():915948. PubMed ID: 36303665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal concentrations of lactic acid potently inactivate HIV.
    Aldunate M; Tyssen D; Johnson A; Zakir T; Sonza S; Moench T; Cone R; Tachedjian G
    J Antimicrob Chemother; 2013 Sep; 68(9):2015-25. PubMed ID: 23657804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
    Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.
    O'Hanlon DE; Moench TR; Cone RA
    PLoS One; 2013; 8(11):e80074. PubMed ID: 24223212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
    Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
    mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of safety and toxicity of a Lactobacillus jensenii producing modified cyanovirin-N in a rhesus macaque vaginal challenge model.
    Brichacek B; Lagenaur LA; Lee PP; Venzon D; Hamer DH
    PLoS One; 2013; 8(11):e78817. PubMed ID: 24265721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do lactobacilli dominate the human vaginal microbiota?
    Witkin SS; Linhares IM
    BJOG; 2017 Mar; 124(4):606-611. PubMed ID: 28224747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commensal Lactobacilli Metabolically Contribute to Cervical Epithelial Homeostasis in a Species-Specific Manner.
    Jimenez NR; Maarsingh JD; Łaniewski P; Herbst-Kralovetz MM
    mSphere; 2023 Feb; 8(1):e0045222. PubMed ID: 36629413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide.
    Yamamoto HS; Xu Q; Fichorova RN
    BMC Microbiol; 2013 Jan; 13():4. PubMed ID: 23298379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic Properties of Lactobacillus crispatus 2,029: Homeostatic Interaction with Cervicovaginal Epithelial Cells and Antagonistic Activity to Genitourinary Pathogens.
    Abramov V; Khlebnikov V; Kosarev I; Bairamova G; Vasilenko R; Suzina N; Machulin A; Sakulin V; Kulikova N; Vasilenko N; Karlyshev A; Uversky V; Chikindas ML; Melnikov V
    Probiotics Antimicrob Proteins; 2014 Dec; 6(3-4):165-76. PubMed ID: 25028263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.
    Trifonova RT; Pasicznyk JM; Fichorova RN
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4005-10. PubMed ID: 17030562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Toll-Like Receptors Differentially Modulates Inflammation in the Human Reproductive Tract: Preliminary Findings.
    Benjelloun F; Quillay H; Cannou C; Marlin R; Madec Y; Fernandez H; Chrétien F; Le Grand R; Barré-Sinoussi F; Nugeyre MT; Menu E
    Front Immunol; 2020; 11():1655. PubMed ID: 32849571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal pH measured in vivo: lactobacilli determine pH and lactic acid concentration.
    O'Hanlon DE; Come RA; Moench TR
    BMC Microbiol; 2019 Jan; 19(1):13. PubMed ID: 30642259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.